Catherine Stace

Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases

Vanessa Baeriswyl, Helen Rapley, Lisa Pollaro et al. · ChemMedChem · 2012 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors

Matthias Eder, Silvia Pavan, Ulrike Bauder‐Wüst et al. · Cancer Research · 2019 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema

Daniel P. Teufel, Gavin Bennett, Helen Harrison et al. · Journal of Medicinal Chemistry · 2018 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers

Hye-Hyun Ahn, Christine A. Carrington, Yizong Hu et al. · Scientific Reports · 2021 · 11 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +17

A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations: implications for peptide-based analgesics

Andrew J. Poole, Laura Frigotto, Matthew E. Smith et al. · Scientific Reports · 2019 · 10 citations · Full text

Medicine, Molecular Biology, Pharmacology +17